Cliff Sosin's position in Cardlytics is currently worth $64.7 Million. That's 6.52% of their entire equity portfolio (5th largest holding). The investor owns 10.20% of the outstanding Cardlytics stock. Cliff Sosin acquired their 5.42 Million shares between 2019 and 2022. So far they never sold any shares in the company. The investor's estimated purchase price is $278 Million, resulting in a loss of 77%.
https://www.investing.com/news/stock-market-news/clifford-sosin-buys-496-million-in-cardlytics-stock-93CH-3349056
Investing.com, 29 days agoAlthough U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the co...
Benzinga, about 1 month agohttps://www.investing.com/news/stock-market-news/cardlytics-insider-clifford-sosin-buys-896m-in-stock-93CH-3343099
Investing.com, about 1 month agoCAS Investment Partners reached a cooperation agreement with digital-ad platform Cardlytics. General Atlantic trimmed its stake in pharmaceutical firm Immuno...
Barron''s, 7 months ago